Financial reports
10-K
2023 FY
Annual report
1 Mar 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
2 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
10-K
2021 FY
Annual report
4 Mar 22
10-Q
2021 Q3
Quarterly report
5 Nov 21
Current reports
8-K
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
8 Feb 24
8-K
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a
12 Dec 23
8-K
Departure of Directors or Certain Officers
6 Nov 23
8-K
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
3 Nov 23
8-K
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
8-K
Other Events
10 May 23
8-K
IRADIMED CORPORATION Announces First Quarter 2023 Financial Results
4 May 23
8-K
Other Events
7 Feb 23
8-K
Entry into a Material Definitive Agreement
3 Feb 23
Registration and prospectus
S-3
Shelf registration
3 Apr 24
S-8
Registration of securities for employees
13 Dec 23
S-8
Registration of securities for employees
4 Sep 20
S-3
Shelf registration
20 Aug 20
424B5
Prospectus supplement for primary offering
18 Dec 15
424B5
Prospectus supplement for primary offering
17 Dec 15
S-3/A
Shelf registration (amended)
3 Dec 15
S-3
Shelf registration
3 Nov 15
S-8
Registration of securities for employees
26 Sep 14
424B4
Prospectus supplement with pricing info
16 Jul 14
Proxies
DEF 14A
Definitive proxy
28 Apr 23
DEF 14A
Definitive proxy
27 Apr 22
DEFA14A
Additional proxy soliciting materials
4 May 21
DEF 14A
Definitive proxy
28 Apr 21
DEFA14A
Additional proxy soliciting materials
3 Jun 20
DEF 14A
Definitive proxy
29 Apr 20
DEF 14A
Definitive proxy
30 Apr 19
DEF 14A
Definitive proxy
27 Apr 18
DEF 14A
Definitive proxy
28 Apr 17
DEFA14A
Additional proxy soliciting materials
29 Apr 16
Other
EFFECT
Notice of effectiveness
4 Sep 20
CORRESP
Correspondence with SEC
2 Sep 20
UPLOAD
Letter from SEC
27 Aug 20
UPLOAD
Letter from SEC
3 Nov 16
CORRESP
Correspondence with SEC
2 Nov 16
UPLOAD
Letter from SEC
25 Oct 16
EFFECT
Notice of effectiveness
7 Dec 15
CORRESP
Correspondence with SEC
4 Dec 15
CORRESP
Correspondence with SEC
3 Dec 15
UPLOAD
Letter from SEC
30 Nov 15
Ownership
SC 13G/A
Susi Roger E.
13 Feb 24
SC 13G/A
Nine Ten Capital Management LLC
12 Feb 24
SC 13G
BlackRock Inc.
9 Feb 24
SC 13G/A
Soleus Capital Master Fund, L.P.
2 Feb 24
4
Roger E. Susi
27 Dec 23
4
Roger E. Susi
22 Dec 23
4
Roger E. Susi
20 Dec 23
4
JAMES B HAWKINS
14 Dec 23
144
Notice of proposed sale of securities
14 Dec 23
144
Notice of proposed sale of securities
13 Dec 23